Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 873 - 880 of 12085 results

Antitrust Concerns Persist For New UN Insurance Group
May 23, 2024| News

Just as "Shall" Means "Shall", "Stay" Means "Stay"
May 22, 2024| Blog| Viewpoint

FERC’s Landmark Transmission Order: Takeaways for Clean Energy and Energy Storage Companies
May 21, 2024| Article| Viewpoint

CFTC Report Calls on Agency to Engage in Rulemaking on AI — AI: The Washington Report
May 20, 2024| Article| Viewpoint

Understanding ESG Ratings: Legal Insights & Perspectives
May 20, 2024| Advisory| Viewpoint

Firm Grows Life Sciences Group in LA
May 20, 2024| News

Why One Major Energy Company Failed Its Say-on-Climate Vote
May 20, 2024| News
News & Press Releases
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
IP Strategist Daniel Brownstone Joins Mintz in New York
July 30, 2025
Daniel Brownstone has joined Mintz as a Member in the firm’s Intellectual Property Division, adding depth to the firm’s IP Prosecution Practice and contributing to its continued growth in the market. He will be based in the firm’s New York office.
Intelligize referenced a recent article by Mintz Member Jacob Hupart in its coverage of the ongoing court challenges to the Securities and Exchange Commission’s climate disclosure rule. Jacob’s piece examines the Eighth Circuit’s decision to hold litigation over the rule “in abeyance.”
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
